Kinetics of Integrilin Limited by Obesity (KILO): A Multi-Center Randomized Clinical Trial

Trial Profile

Kinetics of Integrilin Limited by Obesity (KILO): A Multi-Center Randomized Clinical Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2011

At a glance

  • Drugs Eptifibatide (Primary)
  • Indications Coronary disorders
  • Focus Pharmacodynamics; Pharmacokinetics
  • Acronyms KILO
  • Most Recent Events

    • 01 Dec 2011 Results published in the American Heart Journal.
    • 03 May 2011 New trial record
    • 05 Apr 2011 Results presented at the 60th Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top